Ultraviolet absorbents (UVs) make up a group of industrial
chemicals
that is used in various consumer products and industrial applications.
Due to their extensive production and usage, UVs have been detected
in multiple environmental matrixes. Recently, UVs have garnered significant
attention because of their probable adverse impacts on human health
and the environment. This study examines UVs levels in sunscreens
and isolation cosmetics and further assesses human exposure to UVs
through the application of cosmetics. The total concentrations of
nine UVs in 87 sunscreen and isolation cosmetic products ranged from
75.5 to 4.25 × 104 ng/g. Among them, 2-(2-hydroxy-5-methyl-phenyl)benzotriazole
(UV-P) and 2-hydroxy-4-(octoxy)benzophenone (UV-531) had the highest
concentrations. Use of the EpiSkin model indicated rapid absorption
and strong dermal penetration by UV-328 following 36 h of exposure
with a cumulative absorption rate of 41.8% ± 2.82%. Other congeners
are expected to be distributed in the dermal tissue and donor fluid.
Furthermore, this study explored potential mechanisms implicating
skin biochemical barriers in the metabolism and transport of UVs.
The potential of UVs to act as substrates and inhibitors of P450 enzymes
was assessed, and their metabolites were predicted. Molecular docking
simulations demonstrated that UVs can significantly interact and bind
with three transport proteins in skin: MDR1, OATP2B1, and OATP3A1.
Daily UVs exposure through the skin was assessed, revealing that dermal
absorption levels of UV-P in sunscreen sprays (4.66 × 103 ng/(kg bw day)) and sunscreens (6.01 × 103 ng/(kg bw day)) were close to or exceeded the reference dose (RfD)
and therefore require more attention.